Venetoclax Plus Azacytidine Conditioning Regimen Allo-HSCT for Elderly Patients With Higher-risk Myelodysplastic Syndromes
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Interventional
Study Phase: Phase 1/Phase 2
SUMMARY
The goal of this phase 1/2 trial is to test the safety and efficacy of Venetoclax Plus Azacytidine Conditioning Regimen Allo-HSCT in treating patients with higher-risk MDS.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 70
Healthy Volunteers: f
View:
• The patient should, in the investigator's opinion, be able to meet all clinical trial requirements.
• The patient is willing and able to adhere to the study visit schedule and other protocol requirements.
• The patient should be diagnosed with higher risk MDS according to the standard criteria of the World Health Organization (WHO).
Locations
Other Locations
China
Navy General Hospital
RECRUITING
Beijing
Contact Information
Primary
Liren Qian, PhD
qlr2007@126.com
+861066947192
Time Frame
Start Date: 2024-10-01
Estimated Completion Date: 2030-09-01
Participants
Target number of participants: 54
Treatments
Experimental: Venetoclax Plus Azacytidine Conditioning Regimen Allo-HSCT
Patients were treated by Venetoclax Plus Azacytidine Conditioning Regimen Allo-HSCT
Related Therapeutic Areas
Sponsors
Leads: Navy General Hospital, Beijing